What an assessment involves A typical consultation includes: A focused history of your GLP-1 treatment (medication, dose, duration, rate of weight loss) Review of any symptoms, including subtle or partial ones Examination Review of any existing imaging Discussion of your individual risk profile, with the RELAPSTONE tool where appropriate A clear summary of the options, with no pressure to proceed If imaging is needed, this can be arranged
Mean change in body weight from baseline to week 52 was statistically significantly different between groups: +0.84 kg for IcoSema vs 3.70 kg for semaglutide (ETD 4.54 kg [95% CI 3.84, 5.23]
Hormonal Testing & Therapy: Comprehensive assessments and treatments to optimise your health during weight loss
Tirzepatide data suggests 20-30%
The first is bioavailability
Zepbound and Wegovy have different active ingredients